Fact CheckerSign in

NCT05243030Completed

Developing mHealth to Promote PrEP Use Among Thai Young Men Who Have Sex With Men

Adapting Effective mHealth Interventions to Improve Uptake and Adherence of the HIV Pre-exposure Prophylaxis (PrEP) in Thai Young Men Who Have Sex With Men (MSM).

Source: ClinicalTrials.gov · Last updated 28 Oct 2026

Brief summary (registry, in English)

The goal of this study is to develop and pilot test technology-based interventions to promote Pre-exposure Prophylaxis (PrEP) uptake and adherence among Thai young men who have sex with men (YMSM).

Status (registry)
Completed
Study type
Interventional
Enrollment
119 (actual)
First submitted
18 Jan 2022
Start date
23 Feb 2022
Primary completion date
17 Jul 2025
Lead sponsor
University of Massachusetts, Worcester
Diseases
HIV
NCT number
NCT05243030

What you commit to

  • Study type: Interventional
  • Participants enrolled: 119
  • From 23 Feb 2022 to the primary completion date, 17 Jul 2025
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • In a mutually monogamous relationship of more than 6 months with a partner who recently tested HIV-negative
  • Have a serious cognitive or psychiatric problem that would compromise ability to provide informed consent
  • currently enrolled in another HIV intervention study

Who the study is looking for

  • Age 16-25 years old
  • Men who report sex with men in the past 12 months
  • Confirmed HIV-negative status
  • Self-reported evidence of being at-risk for HIV acquisition, including one of the following in the past 6 months:
    • having a sex with an HIV-positive partner
    • having anal sex
    • without using a condom
    • being diagnosed with an STI or
    • having any illicit drug use (e.g., Amphetamine type stimulants)
  • Able to understand, read and speak Thai
  • Either having not started PrEP (Group 1: PrEP naive) or currently on PrEP but not adherent to PrEP (taking ≤3 pills/week) in the past month (Group 2: PrEP users).

Age in the registry: 16 years to 25 years · Sex: Male · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Institute of HIV Research and Innovation
Coordinator of this site? Confirm its status
BangkokThailandUnknown status
SWING Foundation
Coordinator of this site? Confirm its status
BangkokThailandUnknown status
Rainbow Sky Association of Thailand
Coordinator of this site? Confirm its status
BangkokThailandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.